Sanguisorba officinalis

Common Names: official burnet

Ethnobotanical Studies

Clinical Trials

Inhibitory effects of Sanguisorba officinalis root extract on HYBID (KIAA1199)-mediated hyaluronan degradation and skin wrinkling.

Yoshida H et al (2019).
Int J Cosmet Sci.
PubMed:
30485450

Studies

Identification of octyl gallate, a novel apoptosis-inducing compound for colon cancer therapy, from Sanguisorba officinalis L. by cell membrane chromatography and UHPLC-(Q)TOF-MS/MS.

Summary

Scientists identified octyl gallate from L. extract using advanced chromatography techniques. OG showed significant anti-colon cancer effects in cell lines and mouse models by inhibiting proliferation, inducing apoptosis, and suppressing migration. This research presents a promising approach for developing novel colon cancer therapies.

Ni C et al (2024).
Heliyon.
PubMed:
38933948

Ziyuglycoside II, a triterpene glycoside compound in Sanguisorbae officinalis l. extract, suppresses metastasis in osteosarcoma via CBX4-mediated Wnt/β-catenin signal pathway.

Summary

"ZGS II from Sanguisorba officinalis l. shows promise in treating aggressive osteosarcoma, inhibiting growth and metastasis. Potential new therapy for challenging bone cancer."

Deng Z et al (2024).
Phytomedicine.
PubMed:
38924929

Revealing microbial diversity in buffalo milk with high somatic cell counts: implications for mastitis diagnosis and treatment.

Jiang H et al (2024).
Vet Res Commun.
PubMed:
38874832

Pharmacokinetics of Ziyuglycoside I and Ziyuglycoside II in Rat Plasma by UPLC-MS/MS.

Shen X et al (2024).
Int J Anal Chem.
PubMed:
38463657

Pharmacokinetics of four tannin compounds from Sanguisorba officinalis L. before and after processing by ultra-high-performance liquid chromatography-tandem mass spectrometry.

Wei Y et al (2024).
J Sep Sci.
PubMed:
38403460

Stability in the leaf functional traits of understory herbaceous species after 12-yr of nitrogen addition in temperate larch plantations.

Yan T et al (2023).
Front Plant Sci.
PubMed:
38116147

Hypotensive and Vasorelaxant Effects of Sanguisorbae Radix Ethanol Extract in Spontaneously Hypertensive and Sprague Dawley Rats.

Jung J et al (2023).
Nutrients.
PubMed:
37960162

In Vitro Synergistic Inhibitory Effects of Plant Extract Combinations on Bacterial Growth of Methicillin-Resistant Staphylococcus aureus.

Jeong JY et al (2023).
Pharmaceuticals (Basel).
PubMed:
37895962

Sanguisorba officinalis ethyl acetate extract attenuates ulcerative colitis through inhibiting PI3K-AKT/NF-κB/ STAT3 pathway uncovered by single-cell RNA sequencing.

Summary

Researchers investigated the potential of S. officinalis as a treatment for UC, a serious and incurable illness causing bloody stools. Understanding its molecular mechanism and disease basis could lead to improved treatments with fewer side effects.

Li C et al (2023).
Phytomedicine.
PubMed:
37717310

An antiviral optimized extract from Sanguisorba officinalis L. roots using response surface methodology, and its efficacy in controlling viral hemorrhagic septicemia of olive flounder (Paralichthys olivaceus).

Summary

Scientists have created an optimized extract from Sanguisorba officinalis L. roots that effectively combats viral hemorrhagic septicemia virus in olive flounder, improving their survival and immune response. This extract could be used as an alternative for controlling the virus in fish farms.

Lim JW et al (2023).
Fish Shellfish Immunol.
PubMed:
37689225

Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice.

Summary

A study found that a 95% ethanolic Sweet Orange (SO) extract (SOEE) has potential in inhibiting hepatic steatosis and fibrosis by regulating oxidative stress, fatty acid oxidation, and gut microbiota composition. This could be beneficial for treating non-alcoholic fatty liver disease (NAFLD).

Nam Y et al (2023).
Nutrients.
PubMed:
37686810

In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection.

Chen P et al (2023).
J Ethnopharmacol.
PubMed:
37574016

Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways.

Summary

This study investigated the potential of the traditional Chinese medicine DiYu (DY) to improve the sensitivity and overcome drug resistance in colorectal cancer cells. The results could help identify alternative therapies for drug-resistant cancer.

Zhang W et al (2023).
Heliyon.
PubMed:
37484409

Sanguisorba minor Scop.: An Overview of Its Phytochemistry and Biological Effects.

Summary

This study explores the history, taxonomy, habitat, bioactive components, and biological activities of the genus . It specifically investigates Scop and its potential chemical composition and biological effects. The research also considers electron microscopy and mentions pests and beneficial insects. This study lays the groundwork for further research on Scop.

Tocai Moţoc AC et al (2023).
Plants (Basel).
PubMed:
37299107

Sanguisorba officinalis L. promotes diabetic wound healing in rats through inflammation response mediated by macrophage.

Summary

Chinese medicine Sanguisorba officinalis L. extract (ESO) accelerates diabetic wound healing by reducing inflammation through blocking NF-κB/NLRP3 signaling pathway. Promising treatment option.

Song J et al (2023).
Phytother Res.
PubMed:
37260161

Standardized Sanguisorba officinalis L. Extract Inhibits Adipogenesis and Promotes Thermogenesis via Reducing Oxidative Stress.

Zheng Y et al (2023).
Antioxidants (Basel).
PubMed:
37107257

Gold Nanoparticles Coated with SH-PEG-NH(2) and Loaded with Ziyuglycoside I for Promoting Autophagy in Hematopoietic Stem Cells.

Xiong Y et al (2023).
Int J Nanomedicine.
PubMed:
36974074

Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.

Jiang X et al (2023).
Phytomedicine.
PubMed:
36610353

Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation.

Li H et al (2022).
Front Pharmacol.
PubMed:
36506573

Inhibitory Effects of Selected Medicinal Plants on Bacterial Growth of Methicillin-Resistant Staphylococcus aureus.

Jung IG et al (2022).
Molecules.
PubMed:
36431886

Rapid Profiling of Metabolites Combined with Network Pharmacology to Explore the Potential Mechanism of Sanguisorba officinalis L. against Thrombocytopenia.

Dai Y et al (2022).
Metabolites.
PubMed:
36355157

Dietary supplementation of probiotics fermented Chinese herbal medicine Sanguisorba officinalis cultures enhanced immune response and disease resistance of crucian carp (Carassius auratus) against Aeromonas hydrophila.

Wang T et al (2022).
Fish Shellfish Immunol.
PubMed:
36341871

Sod translocation to restore habitats of the myrmecophilous butterfly Phengaris (Maculinea) teleius on former agricultural fields.

Sevilleja CG et al (2022).
Ecol Evol.
PubMed:
36177109

Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.

Zhang W et al (2022).
Phytomedicine.
PubMed:
34785413

Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma.

Jiang N et al (2021).
Front Pharmacol.
PubMed:
33746755

A new triterpenoid and other constituents with cytotoxic activity from the roots of Sanguisorba officinalis L.

Wang R et al (2021).
Nat Prod Res.
PubMed:
31795750

Phytotherapeutic Activities of Sanguisorba officinalis and its Chemical Constituents: A Review.

Review
Jang E et al (2018).
Am J Chin Med.
PubMed:
29433389